Virtue® Sirolimus AngioInfusion Balloon (“SAB”) is the only non-coated angioplasty system providing protected delivery of…
Virtue® Sirolimus AngioInfusion Balloon (“SAB”) is the only non-coated angioplasty system providing protected delivery of…
Initial clinical results from Phase 2 SUMMIT trial in NonAdvSM along with updated data from…
Initial clinical results from Phase 2 SUMMIT trial in NonAdvSM along with updated data from…
WILMETTE, Ill., Aug. 08, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical…
WILMETTE, Ill., Aug. 08, 2023 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical…
— Agreement Follows Recent Regulatory Approval in Israel of VAZKEPA® to Reduce the Risk of…
— Agreement Follows Recent Regulatory Approval in Israel of VAZKEPA® to Reduce the Risk of…
Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta®…
— VAZKEPA® (icosapent ethyl) accepted by the Scottish Medicines Consortium (SMC) for restricted use within…
— VAZKEPA® (icosapent ethyl) accepted by the Scottish Medicines Consortium (SMC) for restricted use within…
Postpartum depression (PPD) approval based on results from two Phase 3 clinical trials; in the…
Upcoming ISG Provider Lens™ reports will assess providers facilitating intelligent, AI-powered automation to transform and…
Fisker showcases vision for sustainable all-electric vehicle lineup through 2026. Vehicles include Ronin, PEAR, Alaska,…
Over 7,000 CVS Pharmacy Stores to sell the EZ Detect™ Test Simple 2 minute at-home…
Over 7,000 CVS Pharmacy Stores to sell the EZ Detect™ Test Simple 2 minute at-home…
VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) — FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A),…
Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreement Relates…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
NEW YORK–(BUSINESS WIRE)–Massive Bio and Asklepieia will utilize their innovative technologies to provide oncologists and…